Clinical Trial Update: Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update indicates that SHR-1819 Injection is being investigated in Phase 2 and Phase 3 studies for efficacy and safety in adults with Prurigo No…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prurigo Nodularis

Drugs mentioned

• SHR-1819

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Prurigo Nodularis | Phase 2, Phase 3 | Status: RECRUITING